✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals
Market Cap
₹3,133 Cr.
P/E
20.52
About
Aarti Drugs Limited, established in 1984, is part of Aarti Group of Industries with a strong R&D Division in Maharashtra. The company manufactures APIs, Pharma Intermediates, Specialty Chemicals, and … Read more
Aarti Drugs Limited, established in 1984, is part of Aarti Group of Industries with a strong R… Read more
Low
330
52W Range
High
635
  • Aarti Drugs
  • Morepen Laboratories
  • Solara Active Pharma
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

8 Yes

Positive for this company

2 Neutral

Neutral for this company

7 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Therapeutic Area Break-Up

Operational Metrics

    Select a Metric
    • APIs Production Capacity (MTPA)
    • R&D as a % of Total Sales (%)
    Peer Comparison
    Brands
    Nizoral
    Corporate Actions
    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less
    Customers
    • Abbott India Ltd.
    • Alembic Pharmaceuticals Ltd.
    • Cipla Ltd.
    • Indoco Remedies Ltd.
    • Kopran Ltd.
    FAQs on Aarti Drugs Ltd. Business

    Aarti Drugs Limited, a key player in the pharmaceutical industry, specializes in manufacturing APIs, Pharma Intermediates, Specialty Chemicals, and Formulations including Ciprofloxacin Hydrochloride and Metronidazole.

    Aarti Drugs major competitors are Morepen Laboratories, Solara Active Pharma, Bajaj Healthcare, SMS Pharmaceuticals, IOL Chem & Pharma, Themis Medicare, Hester Biosciences.
    Market Cap of Aarti Drugs is ₹3,101 Crs.
    While the median market cap of its peers are ₹1,886 Crs.

    Aarti Drugs seems to be less financially stable compared to its competitors.
    Altman Z score of Aarti Drugs is 3.96 and is ranked 6 out of its 8 competitors.

    Company Filing
    Discussions & Analysis
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material